FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.
Saved in:
| Title: | FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia. |
|---|---|
| Authors: | Ondrisova L; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Seda V; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Hlavac K; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Pavelkova P; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Hoferkova E; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Chiodin G; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Kostalova L; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Mladonicka Pavlasova G; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia., Filip D; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Vecera J; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Zeni PF; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia., Oppelt J; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia., Kahounova Z; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia., Vichova R; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia., Soucek K; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia., Panovska A; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Plevova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Pospisilova S; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Simkovic M; Fourth Department of Internal Medicine-Haematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czechia., Vrbacky F; Fourth Department of Internal Medicine-Haematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czechia., Lysak D; Department of Haematology and Oncology, University Hospital Pilsen, Pilsen, Czechia., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Maiques-Diaz A; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Charalampopoulou S; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Martin-Subero JI; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Doubek M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Forconi F; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, United Kingdom., Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia., Mraz M; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2024 Oct 22; Vol. 134 (23). Date of Electronic Publication: 2024 Oct 22. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39436708 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ondrisova+L%22">Ondrisova L</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Seda+V%22">Seda V</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Hlavac+K%22">Hlavac K</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Pavelkova+P%22">Pavelkova P</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Hoferkova+E%22">Hoferkova E</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Chiodin+G%22">Chiodin G</searchLink>; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kostalova+L%22">Kostalova L</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Mladonicka+Pavlasova+G%22">Mladonicka Pavlasova G</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Filip+D%22">Filip D</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Vecera+J%22">Vecera J</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Zeni+PF%22">Zeni PF</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Oppelt+J%22">Oppelt J</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Kahounova+Z%22">Kahounova Z</searchLink>; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Vichova+R%22">Vichova R</searchLink>; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Soucek+K%22">Soucek K</searchLink>; Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Panovska+A%22">Panovska A</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Plevova+K%22">Plevova K</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Pospisilova+S%22">Pospisilova S</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Simkovic+M%22">Simkovic M</searchLink>; Fourth Department of Internal Medicine-Haematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czechia.<br /><searchLink fieldCode="AU" term="%22Vrbacky+F%22">Vrbacky F</searchLink>; Fourth Department of Internal Medicine-Haematology, University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove, Charles University, Prague, Czechia.<br /><searchLink fieldCode="AU" term="%22Lysak+D%22">Lysak D</searchLink>; Department of Haematology and Oncology, University Hospital Pilsen, Pilsen, Czechia.<br /><searchLink fieldCode="AU" term="%22Fernandes+SM%22">Fernandes SM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Davids+MS%22">Davids MS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Maiques-Diaz+A%22">Maiques-Diaz A</searchLink>; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Charalampopoulou+S%22">Charalampopoulou S</searchLink>; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Martin-Subero+JI%22">Martin-Subero JI</searchLink>; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Brown+JR%22">Brown JR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Doubek+M%22">Doubek M</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Forconi+F%22">Forconi F</searchLink>; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Haematology Department, Cancer Care Directorate, University Hospital Southampton NHS Trust, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mayer+J%22">Mayer J</searchLink>; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Mraz+M%22">Mraz M</searchLink>; Molecular Medicine, CEITEC Masaryk University, Brno, Czechia.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czechia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2024 Oct 22; Vol. 134 (23). <i>Date of Electronic Publication: </i>2024 Oct 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39436708 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI173770 Languages: – Code: eng Text: English Titles: – TitleFull: FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ondrisova L – PersonEntity: Name: NameFull: Seda V – PersonEntity: Name: NameFull: Hlavac K – PersonEntity: Name: NameFull: Pavelkova P – PersonEntity: Name: NameFull: Hoferkova E – PersonEntity: Name: NameFull: Chiodin G – PersonEntity: Name: NameFull: Kostalova L – PersonEntity: Name: NameFull: Mladonicka Pavlasova G – PersonEntity: Name: NameFull: Filip D – PersonEntity: Name: NameFull: Vecera J – PersonEntity: Name: NameFull: Zeni PF – PersonEntity: Name: NameFull: Oppelt J – PersonEntity: Name: NameFull: Kahounova Z – PersonEntity: Name: NameFull: Vichova R – PersonEntity: Name: NameFull: Soucek K – PersonEntity: Name: NameFull: Panovska A – PersonEntity: Name: NameFull: Plevova K – PersonEntity: Name: NameFull: Pospisilova S – PersonEntity: Name: NameFull: Simkovic M – PersonEntity: Name: NameFull: Vrbacky F – PersonEntity: Name: NameFull: Lysak D – PersonEntity: Name: NameFull: Fernandes SM – PersonEntity: Name: NameFull: Davids MS – PersonEntity: Name: NameFull: Maiques-Diaz A – PersonEntity: Name: NameFull: Charalampopoulou S – PersonEntity: Name: NameFull: Martin-Subero JI – PersonEntity: Name: NameFull: Brown JR – PersonEntity: Name: NameFull: Doubek M – PersonEntity: Name: NameFull: Forconi F – PersonEntity: Name: NameFull: Mayer J – PersonEntity: Name: NameFull: Mraz M IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 10 Text: 2024 Oct 22 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 134 – Type: issue Value: 23 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |